Literature DB >> 8566028

B1 and B2 cells differ in their potential to switch immunoglobulin isotype.

D M Tarlinton1, M McLean, G J Nossal.   

Abstract

The ability of purified B1a (Ly-1 B) and B2 cells to switch immunoglobulin isotype was assessed by limiting dilution analysis in two in vitro culture systems. When stimulated in the presence of interleukins-4 and -5 by either lipopolysaccharide or CD40 ligand, the frequency of IgG1 precursors in the B1a population was at most one third that of IgM precursors. In B2 cells, however, the frequency of IgG1 precursors was up to seven times that of IgM precursors. B1a cells were shown to respond to interleukin-4 by virtue of up-regulating major histocompatibility complex class II expression when exposed to the cytokine, precluding non-responsiveness as a reason for not switching to IgG1. Indeed, interleukin-4 was found to specifically induce transcription of the germ-line IgG1 constant region locus in B1a cells as it did in B2 cells. Collectively these results suggest that the ability of B1 cells to respond to isotype switch commitment factors such as interleukin-4 may be secondary to the production of IgM by these cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566028     DOI: 10.1002/eji.1830251228

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  Somatic hypermutation in human B cell subsets.

Authors:  N S Longo; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Generation and analysis of Siah2 mutant mice.

Authors:  Ian J Frew; Vicki E Hammond; Ross A Dickins; Julian M W Quinn; Carl R Walkley; Natalie A Sims; Ralf Schnall; Neil G Della; Andrew J Holloway; Matthew R Digby; Peter W Janes; David M Tarlinton; Louise E Purton; Matthew T Gillespie; David D L Bowtell
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

Review 4.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 5.  Therapeutic Potential of B-1a Cells in COVID-19.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  Shock       Date:  2020-11       Impact factor: 3.454

6.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.

Authors:  H P Brezinschek; S J Foster; R I Brezinschek; T Dörner; R Domiati-Saad; P E Lipsky
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 8.  The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.

Authors:  Héloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2016-10-17       Impact factor: 10.121

9.  A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice.

Authors:  Xuemei Zhong; Stanley Lau; Chunyan Bai; Nicolas Degauque; Nichol E Holodick; Scott J Steven; Joseph Tumang; Wenda Gao; Thomas L Rothstein
Journal:  Arthritis Rheum       Date:  2009-12

10.  Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Authors:  Tâm D Quách; Nely Rodríguez-Zhurbenko; Thomas J Hopkins; Xiaoti Guo; Ana María Hernández; Wentian Li; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.